Sai Li

Title: The Innovations of Inventor Sai Li

Introduction

Sai Li is a notable inventor based in Shenyang, China. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on quinoline and cinnoline derivatives. His research focuses on developing compounds that have potential applications in treating diseases associated with abnormal expression of c-Met kinase, especially cancer.

Latest Patents

Sai Li holds a patent for "Quinoline and cinnoline derivatives and their applications." This invention relates to a series of quinoline and cinnoline derivatives of general formula I, along with their pharmaceutically acceptable salts, hydrates, solvates, or prodrugs. The compounds of general formula I exhibit potent inhibitory activity against c-Met kinase. Furthermore, the invention encompasses the uses of these compounds for preparing medicaments aimed at treating and preventing diseases caused by abnormal c-Met kinase expression, with a particular emphasis on cancer treatment and prevention.

Career Highlights

Throughout his career, Sai Li has been associated with Shenyang Pharmaceutical University and Shenyang Pharmaceutical University (Benxi) Pharmaceutical Science and Technology Co., Ltd. His work in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Some of his notable coworkers include Ping Gong and Yanfang Zhao, who have collaborated with him on various projects. Their combined expertise has further enriched the research environment in which Sai Li operates.

Conclusion

Sai Li's innovative work in the field of medicinal chemistry, particularly his research on quinoline and cinnoline derivatives, showcases his commitment to advancing medical science. His contributions have the potential to impact cancer treatment significantly.